Baillie Gifford & Co’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-171
| Closed | -$24.2K | – | 337 |
|
|
2023
Q1 | $24.2K | Buy |
171
+26
| +18% | +$3.68K | ﹤0.01% | 327 |
|
|
2022
Q4 | $22.7K | Hold |
145
| – | – | ﹤0.01% | 332 |
|
|
2022
Q3 | $18K | Hold |
145
| – | – | ﹤0.01% | 348 |
|
|
2022
Q2 | $19K | Hold |
145
| – | – | ﹤0.01% | 344 |
|
|
2022
Q1 | $20K | Hold |
145
| – | – | ﹤0.01% | 363 |
|
|
2021
Q4 | $25K | Hold |
145
| – | – | ﹤0.01% | 349 |
|
|
2021
Q3 | $21K | Sell |
145
-15
| -9% | -$2.17K | ﹤0.01% | 366 |
|
|
2021
Q2 | $21K | Hold |
160
| – | – | ﹤0.01% | 349 |
|
|
2021
Q1 | $21K | Buy |
160
+12
| +8% | +$1.58K | ﹤0.01% | 327 |
|
|
2020
Q4 | $18K | Buy |
+148
| New | +$18K | ﹤0.01% | 331 |
|
|
2013
Q4 | – | Sell |
-2,665
| Closed | -$165K | – | 210 |
|
|
2013
Q3 | $165K | Hold |
2,665
| – | – | ﹤0.01% | 197 |
|
|
2013
Q2 | $162K | Buy |
+2,665
| New | +$162K | ﹤0.01% | 173 |
|